Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Braster's share price for the quarter that ended in Mar. 2024 was zł0.58. Braster's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 29.38 Mil. Therefore, Braster's market cap for the quarter that ended in Mar. 2024 was zł17.04 Mil.
Braster's quarterly market cap
stayed the same
from Sep. 2023 (zł17.04 Mil) to Dec. 2023 (zł17.04 Mil) and
stayed the same
from Dec. 2023 (zł17.04 Mil) to Mar. 2024 (zł17.04 Mil).
Braster's annual market cap
increased
from Dec. 2021 (zł22.66 Mil) to Dec. 2022 (zł22.83 Mil) but then
declined
from Dec. 2022 (zł22.83 Mil) to Dec. 2023 (zł17.04 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Braster's Enterprise Value for Today is zł28.17 Mil.
Braster (WAR:BRA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Braster Market Cap Related Terms
Braster Market Cap Historical Data
* Premium members only.
The historical data trend for Braster's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Braster's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Braster Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Braster's Market Cap distribution charts can be found below:
* The bar in red indicates where Braster's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Braster's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braster (WAR:BRA) has a Market Cap of zł17.04 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Braster and its competitors.
Is Braster's Market Cap too high?
Braster's current Market Cap is zł17.04 Mil. Overall, Braster has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Braster's Market Cap compare to ABT and MDT?
Braster's Market Cap of zł17.04 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 118.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.46, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Braster and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Braster's current Market Cap is zł17.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braster stock overvalued right now?
Braster (WAR:BRA) has a current Market Cap of zł17.04 Mil. The current Market Cap is zł17.04 Mil. Braster's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Braster (WAR:BRA), the current Market Cap is zł17.04 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Braster SA offers solutions for monitoring breasts health which is an adjunct to examinations such as breast ultrasound and mammography. The system of breast examination developed for both home use by individual customers as well as professional use by healthcare professionals.
4GF Score
Get the complete analysis for WAR:BRA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:BRA has been successfully added to your 
